Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Postmenopausal Osteoporosis: PROLIA is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures. In postmenopausal women with osteoporosis, PROLIA increases bone mineral density (BMD) and reduces the incidence of hip, vertebral and non-vertebral fractures.
Bone Loss in Patients Undergoing Hormone Ablation for Cancer: PROLIA is indicated for the treatment of bone loss in patients undergoing hormone ablation for prostate or breast cancer at increased risk of fractures. In patients with prostate cancer, PROLIA reduces the incidence of vertebral fractures.
Male Osteoporosis: PROLIA is indicated for the treatment of osteoporosis in men at the increased risk of fractures.
Glucocorticoid-Induced Osteoporosis: PROLIA is indicated for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture.

Prolia Indications/Uses

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma